Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07066761

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)

Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Lateral Suspension (LatGYNious)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
85 (estimated)
Sponsor
A.M.I. Agency for Medical Innovations GmbH · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the clinical investigation is to verify that the investigational device (LatGYNious) is appropriate to significantly improve the pelvic organ prolapse in patients.

Detailed description

LatGYNious is a preformed mesh implant which combines two types of polypropylene meshes with different properties. The mesh body is made of ultra-light monofilament polypropylene with a wide hexagonal pore structure with a high level of elasticity. A reinforced mesh material with a smaller pore structure is used for the mesh arms, which achieves a strong lateral fixation. The overlap area of the two mesh types is designed to combine the properties of both structures. In case of a uterus preserving approach, the posterior part of the mesh body is removed. The aim of the present study is to generate clinical data to show the safety and performance of LatGYNious for the treatment of female pelvic organ prolapse.

Conditions

Interventions

TypeNameDescription
DEVICELaparoscopic lateral suspension with surgical mesh (LatGYNious)Laparoscopic lateral suspension with LatGYNious (with uterus preservation or after hysterectomy)

Timeline

Start date
2025-07-01
Primary completion
2026-12-01
Completion
2027-07-01
First posted
2025-07-15
Last updated
2025-07-18

Locations

5 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT07066761. Inclusion in this directory is not an endorsement.